73
Views
3
CrossRef citations to date
0
Altmetric
Letter to the Editor

Clonal spread of carbapenem-resistant Acinetobacter baumannii isolates among Bulgarian critically ill patients undergoing renal replacement therapy (2016–2018)

, , , &
Pages 430-433 | Received 22 Jan 2020, Accepted 30 Jan 2020, Published online: 11 Feb 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Elizabeth Palavecino, Shermalyn R. Greene & Abdullah Kilic. (2022) Characterisation of carbapenemase genes and antibiotic resistance in carbapenem-resistant Acinetobacter baumannii between 2019 and 2022. Infectious Diseases 54:12, pages 951-953.
Read now

Articles from other publishers (2)

Nadezhda K. Fursova, Mikhail V. Fursov, Evgeny I. Astashkin, Anastasiia D. Fursova, Tatiana S. Novikova, Angelina A. Kislichkina, Angelika A. Sizova, Galina N. Fedyukina, Ivan A. Savin & Olga N. Ershova. (2023) Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Causing Nosocomial Meningitis in the Neurological Intensive Care Unit. Microorganisms 11:8, pages 2020.
Crossref
Tanya V. Strateva, Ivo Sirakov, Temenuga J. Stoeva, Alexander Stratev & Slavil Peykov. (2023) Phenotypic and Molecular Characteristics of Carbapenem-Resistant Acinetobacter baumannii Isolates from Bulgarian Intensive Care Unit Patients. Microorganisms 11:4, pages 875.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.